Orbital Complication of Rhinosinusitis: Orbital Cellulitis Emergency Management

The orbit is anatomically close to the paranasal sinuses: medial wall (lamina papyracea — ethmoid sinus), inferior wall (maxillary sinus roof), superior wall (frontal sinus floor), apex (sphenoid connection). Lamina papyracea is very thin (0.2-0.4 mm) — the anatomic route for ethmoidal spread.

Orbital septum: fibrous layer separating orbital contents from superficial skin. Preseptal (anterior to septum) and postseptal (orbital contents) compartments — clinically critical because preseptal cellulitis is milder, postseptal severe (vision risk + intracranial spread).

Spread mechanisms: (1) direct — lamina papyracea defect or thin bone (commonest, ethmoidal); (2) venous — orbital veins connect with paranasal veins (no valves — bidirectional flow), infection spreads retrograde; (3) lymphatic — orbital lymphatic drainage shared with sinuses; (4) adjacent — frontal sinus floor or maxillary sinus roof erosion.

Aetiologic microorganisms — paediatric (<9 years): Streptococcus pneumoniae (commonest), Haemophilus influenzae (decreased after Hib vaccine), Moraxella catarrhalis, Staphylococcus aureus; ≥9 years: aerobes + anaerobes — Streptococcus, Staphylococcus (incl. MRSA), anaerobes (Peptostreptococcus, Fusobacterium, Bacteroides).

Post-Hib vaccination epidemiology: Haemophilus influenzae type B vaccine (since 1985) caused major decline — formerly the cause in 50%+ of paediatric cases; minor in vaccinated populations. Turkey added Hib in routine schedule (extended programme since 1997).

Risk factors: viral upper respiratory tract infection (sinusitis trigger), allergic rhinitis (mucosal inflammation), dental infection (odontogenic maxillary sinusitis), trauma (penetrating), immunosuppression (HIV, chemotherapy, diabetes), chronic rhinosinusitis (acute exacerbation), anatomic anomalies (septal deviation, ostiomeatal narrowing).

Age group: paediatric (especially 7-12 years, ethmoid sinus mature) most common — 70-80% of orbital cellulitis is paediatric. Adult cases tend to be more complex (diabetic, immunocompromised, on chronic sinusitis background).

Incidence: even in the era of antibiotic stewardship orbital cellulitis remains significant — paediatric 1.6-3.5/100,000 annually. Lower in adults. We expand on the clinical framework in our general ENT services.

Chandler et al. (1970) classified orbital complications of sinusitis into 5 types by anatomic severity — used as a management guide in modern ENT practice.

Type I — preseptal cellulitis: infection of skin and subcutaneous tissue anterior to the orbital septum. Findings: red, swollen, warm, painful lids; free eye movement (NO motility restriction); vision normal; NO proptosis; low-moderate fever. Most resolve with oral antibiotic (admission rare).

Type II — postseptal (orbital) cellulitis: infection has crossed the orbital septum — orbital contents (fat and muscles) diffusely infected. Findings: lid redness + oedema + warmth, mild proptosis (1-3 mm), eye movement restriction begins, vision usually normal but needs close monitoring. Hospitalisation + IV antibiotic standard.

Type III — subperiosteal abscess: localised abscess beneath the orbital wall (usually lamina papyracea — medial wall, ethmoidal). Findings: significant proptosis (typically lateral or inferolateral — abscess displaces eye), painful ophthalmoplegia (restricted movement), vision threat (compression), prominent lid swelling. Early surgical drainage planning needed.

Type IV — orbital abscess: abscess within orbital contents (beyond subperiosteal — between fat and muscle). Findings: severe proptosis, complete ophthalmoplegia, vision severely reduced or lost, RAPD positive, severe oedema, systemic features (high fever, sepsis risk). Emergency surgical drainage.

Type V — cavernous sinus thrombosis: infection spreads via veins to cavernous sinus + thrombosis. Findings: initially unilateral then rapidly bilateral eye involvement, ophthalmoplegia (CN III, IV, VI), V1 + V2 sensory deficits, fundus venous congestion, papilloedema, high fever, altered mental status, sepsis. Life-threatening (mortality 20-40% modern; historically much higher). Emergency multidisciplinary — anticoagulation + IV antibiotic + debated surgery.

Bedside examination items: (1) visual acuity (Snellen or finger counting — drops rapidly in severe disease); (2) ocular motility (6 directions — restriction: orbital abscess or severe cellulitis); (3) pupillary response + RAPD (afferent defect — optic nerve involvement); (4) conjunctiva (chemosis — swelling; purulent discharge); (5) skin (warmth, redness, tenderness); (6) proptosis (Hertel exophthalmometer); (7) fever, mental status.

RAPD (Relative Afferent Pupillary Defect) matters: early sign of optic nerve or retinal compression. Positive RAPD warrants urgent surgical decision — the last chance to prevent vision loss.

Mechanisms of vision loss: direct optic nerve pressure (subperiosteal abscess), inflammatory oedema (orbital cellulitis), ischaemia (vascular compression), extinction (retina/optic nerve ischaemic sequel). Vision loss can become irreversible within 4-6 hours.

Rapid diagnosis is critical — suspected case warrants emergency imaging + hospitalisation + IV antibiotic. Delay risks vision loss or intracranial spread.

History: sinusitis history (how many days, which symptoms — congestion, purulent discharge, headache), eye symptom onset (hours-days), trauma, dental (odontogenic), immune status (diabetes, chemotherapy), vaccination (Hib), prior ENT or ophthalmology procedures.

Examination: full ENT (nasal endoscopy — purulent discharge, polyps, mucosal hyperaemia) + ophthalmology (visual acuity, RAPD, motility, fundus, proptosis measurement), systemic (fever, mental status, neurology — especially cranial nerves).

Imaging — contrast orbital CT: first line. Axial + coronal. Evaluates: sinuses (ethmoid, maxillary, frontal, sphenoid — opacification, mucosal thickening, fluid level, bone destruction), orbital soft tissue (preseptal vs postseptal spread), subperiosteal abscess (medial wall — ethmoidal lamina papyracea, fat displacement), orbital abscess (abscess cavity in orbital fat), cavernous sinus (enlargement, thrombosis sign — low-density area), intracranial structures (epidural abscess, brain abscess).

MRI indications: suspected cavernous sinus thrombosis (MRV — magnetic resonance venography evaluates thrombosis best), intracranial spread (meningitis, brain abscess), soft tissue detail.

Laboratory: complete blood count (leukocytosis + left shift — bacterial), CRP + ESR (elevated), blood culture (suspected bacteraemia — especially in children, sepsis features), procalcitonin (modern marker), electrolytes, creatinine (antibiotic dosing), coagulation (if cavernous sinus thrombosis).

Microbiological sampling: nasal discharge culture (from ostiomeatal complex), pus culture during abscess drainage (most valuable — direct pathogen) — culture + sensitivities.

Differential diagnosis: allergic blepharitis (lid swelling + itch, redness usually bilateral), hordeolum/chalazion (localised lid nodule), contact dermatitis (allergic), Graves' orbitopathy (chronic proptosis, motility restriction — not acute), orbital tumour (chronic painless proptosis), orbital rhabdomyosarcoma (paediatric, can mimic acute), orbital pseudotumour (idiopathic orbital inflammatory disease — steroid-responsive).

Paediatric considerations: examination difficult, crying + irritability + fever + lid swelling combined. Low threshold for imaging — sedated CT when needed. Children may progress faster (limited compensatory mechanisms). More detail: sinusitis page.

Hospitalisation is mandatory for all Chandler II+ cases. Mild Type I (preseptal) cases may be managed as outpatient with oral antibiotic + close monitoring; if progression risk, prefer admission.

Initial IV antibiotic (pending culture): broad-spectrum, common-pathogen coverage. Paediatric: ceftriaxone (50-100 mg/kg/day) + vancomycin (40-60 mg/kg/day for MRSA) + metronidazole (anaerobes, particularly ≥9 years). Adult: ampicillin-sulbactam (3 g IV q6h) or ceftriaxone 2 g IV + metronidazole; vancomycin added if MRSA risk.

Duration: IV initially (at least 24-72 hours until clinical improvement or after surgery), oral switch (total 10-14 days, or 4-6 weeks if chronic sinusitis). Clinical improvement: fever resolves, leukocytosis falls, oedema/proptosis regresses, vision stable/improving.

Adjunctive steroid (dexamethasone) in paediatric is debated — recent data suggest short course after 24-48 h reduces inflammation; bacterial control should first be assured.

Surgical indications: (1) Chandler III (subperiosteal abscess — particularly ≥1 cm or vision-threatening); (2) Chandler IV (orbital abscess); (3) Chandler I-II non-response (24-48 hours of IV antibiotic); (4) progressive visual decline; (5) RAPD positive; (6) intracranial spread signs.

Surgical approach — modern gold standard: endoscopic transnasal. Endoscope through nasal cavity → middle meatus → ethmoid labyrinth → lamina papyracea window + drainage of medial subperiosteal abscess + ethmoid sinus surgery (source control) + ostia opening. Pros: minimally invasive, fast, no facial/orbital incision, good cosmesis.

External approach (alternative): orbital wall incision (Lynch-Howarth — medial; transconjunctival), Caldwell-Luc (maxillary sinus), frontal osteoplastic. Considered if endoscopic inadequate or very severe.

Cavernous sinus thrombosis management: hospitalisation, IV broad-spectrum antibiotic (vancomycin + ceftriaxone + metronidazole), anticoagulation (heparin — debated, modern protocols often recommend), steroid (debated — anti-inflammatory in some protocols). Cavernous sinus drainage usually avoided (uncontrolled bleeding risk). Multidisciplinary — ENT + neurology + neurosurgery + infectious disease + critical care. Mortality 20-40% with modern care, vision loss in >50%.

Postoperative/post-treatment: close ophthalmology follow-up (hourly visual acuity + motility + RAPD first 24-48 h), monitoring symptoms + parameters during antibiotic course, long-term ophthalmology (visual acuity, optic nerve), ENT (sinus status, chronic sinusitis development).

Late complications: permanent vision loss (delayed diagnosis, optic nerve or retinal ischaemia), ophthalmoplegia (extraocular muscle fibrosis), persistent proptosis (orbital fat scarring), chronic sinusitis (incompletely eradicated), epilepsy (post-intracranial spread), cranial nerve injury (cavernous sinus thrombosis sequel), cosmetic (peri-orbital skin scar or persistent swelling).

Prevention: early treatment of acute sinusitis (antibiotic for suspected bacterial ARS), Hib vaccination in children, chronic sinusitis management (CRS — topical steroid + surgery if needed), diabetes control (immune sufficiency), dental health (prevent odontogenic sinusitis). We share patient experiences on our Istanbul ENT services.